NEW YORK--(BUSINESS WIRE)-- Tracer Biotechnologies, a leader in blood-based molecular diagnostics for cancer, is pleased to announce a strategic partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an expansion of its QIAseq NGS portfolio to offer a one-day workflow for ...

Requirements placed on samples to be processed continue to grow. In both academic settings and industry, automation solutions are becoming more and more important. The purification of genomic DNA ...

Qiagen (NYSE:QGEN) signed an agreement to develop a companion diagnostic test for Servier's acute myeloid leukemia (AML) drug Tibsovo. AML is a cancer that starts in the bone marrow and moves into the ...